フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER ...
TORONTO, May 28 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. ("DRAXIS") (TSX: DAX) (NASDAQ:DRAX) announced today the completion of the statutory...
Court approves acquisition of DRAXIS by Jubilant TORONTO, May 27 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. ("DRAXIS") (TSX: DAX...
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant...
TORONTO, May 23 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. ("DRAXIS" or the "Company") (TSX: DAX) (NASDAQ:DRAX) announced today that the plan...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment...
MONTREAL, May 9 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. (TSX: DAX) (NASDAQ:DRAX) reported first quarter financial results for the three...
MONTREAL, May 6 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. (TSX: DAX) (NASDAQ:DRAX) will report financial and operating results for its First...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 7) UNDER THE SECURITIES EXCHANGE ACT OF...
QuickLinks -- Click here to rapidly navigate through this document SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 6-K REPORT...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約